The role of chemokines in tissue inflammation and autoimmunity in renal diseases

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 3, 1998, Pages 281-287

  Lloyd, Clare ^a   Gutierrez Ramos, Jose Carlos ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CYCLOPHOSPHAMIDE; CYTOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; NEUTRALIZING ANTIBODY; POLYPEPTIDE; PROTEIN; PUROMYCIN AMINONUCLEOSIDE; RANTES;

ARTICLE; AUTOIMMUNITY; CYTOKINE PRODUCTION; GENE EXPRESSION; GRAFT REJECTION; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; INTERNALIZATION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0031838536     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199805000-00008     Document Type: Article

References (41)

1. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15:675-705.
2. •) provide an overview of the chemokine field.
3. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo J-A, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997; 387:611-617. This paper describes a member of the newest class of chemokines.
4. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385:640-644. This paper describes a member of the newest class of chemokines.
5. 3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91:521-530.
6. Laudanna C, Campbell JJ, Butcher EC. Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science 1996; 271:981-983
7. Witt DP, Lander AD Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994; 4:394-400.
8. Ebnet K, Kaldijian EP, Anderson AO, Shaw S. Orchestrated infornation-transfer underlying leucocyte-endothelial interactions. Annu Rev Immunol 1996; 14:155-177.
9. Hoogewerf AJ, Kuschert GSV, Proudfoot AEI, Borlat F, Clark-Lewis I, Power CA, Wells TNC. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 1997; 36:13570-13578.
10. Haribabu B, Richardson RM, Fisher I, Sozzani S, Peiper S, Horuk R, et al. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem 1997; 272:28762-28731
11. Mueller SG, White JR, Schraw WP, Lam V, Richmond A. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J Biol Chem 1997; 272:8207-8214.
12. Aramori I, Zhang J, Fergusson SS, Bieniasz PD, Cullen B, Caron MG. Molecular mechanism of desensitization of the chemokine receptor CCR5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 1997; 16:4606-4616. This paper describes experiments that show that, in response to chemokines, CCR-5 is desensitized, phosphorylated, and sequestered only after overexpression of G-protein coupled receptor kinases and β-arrestins. However, the function of CCR5 as an HIV coreceptor is unaffected.
13. Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995; 269:1727-1730.
14. Taub DD, Ortaldo JR, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJB. Chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukocyte Biol 1996; 59:81-89.
15. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 1997; 158:4129-4136.
16. Sallusto F, MacKay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277:2005-2007. This paper shows for the first time that a chemokine receptor is selectively expressed on T-cell subsets. An antibody to CCR3 was used to isolate T cells from peripheral blood that give rise to Th2-polarized cell lines and to identify Th2 cells derived from naive T cells in vitro.
17. Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR. Immune modulation with interleukin-4 and interteukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 1997; 27:530-537.
18. Frade JMR, Llorente M, Mellado M, Alcami J, Gutierrez-Ramos JC, Zaballos A, et al. The amino-terminal domain of the CCR2 chemokine receptor acts as a coreceptor for HIV-1 infection. J Clin Invest 1997; 100:497-502.
19. Moore JP. Coreceptors: implications for HIV pathogenesis. Science 1997; 276:51-52.
20. Broder CC, Collman RG. Chemokine receptors and HIV. J Leukocyte Biol 1997; 62:20-29.
21. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-377.
22. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber C, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-725
23. Schlondortf D, Nelson PJ, Lucknow B, Banas B. Chemokines and renal disease. Kidney Int 1997; 51:610-621. This review is an in-depth analysis of the role of chemokines in a variety of murine and human renal diseases.
24. Tam FWK, Karkar AM, Smith J, Yoshimura T, Steinkasserer A, Roland K, et al. Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis. Kidney Int 1996; 49:715-721.
25. Wu X, Dolecki GJ, Sherry B, Zagorski J, Lefkowith JB. Chemokines are expressed in a myeloid cell-dependent fashion and mediate distinct functions in immune complex glomerulonephritis in the rat. J Immunol 1997; 158:3917-3924.
26. Tang WW, Qi M, Warren JS. Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int 1996; 50:665-671.
27. Fujinaka H, Yamamoto T, Takeya M, Feng L, Kawasaki K, Yaoita E, et al. Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein antibody in WKY rats. J Am Soc Nephrol 1997; 8:1174-1178.
28. Lloyd CM, Minto AW, Dorff ME, Proudfoot A, Wells TNC, Salant DJ, Gutierrez-Ramos J-C. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185:1371-1380. This study involved blocking the functions of MCP-1 or RANTES during development of crescentic nephritis using neutralizing antibodies or a RANTES receptor antagonist. Evidence is provided to show that MCP-1 is critical, not only in the accumulation of leukocytes in the kidney, but also in the progression of disease.
29. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA.α-Melanocyte-stimulating hormone protects against renal injury after ischemia reperfusion injury in mice and rats. J Clin Invest 1997; 99:1165-1172.
30. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NA. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. J Clin Invest 1997; 99:2682-2690.
31. Zoja C, Xue-Hui L, Donadelli R, Abbate M, Testa D, Corna D, et al. Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol 1997; 8:720-729.
32. Tang WW, Qi M, Warren JS, Van GY. Chemokine expression in experimental tubular nephritis. J Immunol 1997; 159:870-876.
33. Cockwell P, Girdlestone J, Brooks CJ, Adu D, Savage CO. In situ analysis of fractalkine mRNA in human renal inflammation [abstract]. J Am Soc Nephrol 1997; 8:453.
34. Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996; 271:17779-17784.
35. Lloyd CM, Wen D, Proudloot AEI, Dorf M, Salant D, Gutierrez-Ramos JC. MCP-1 plays a role in expression of RANTES and in cell proliferation during murine crescentic nephritis [abstract]. J Am Soc Nephrol 1997; 8:478.
36. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W. Strom TB. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94:695-700. The authors show that polymerase chain reaction can be an accurate method of detecting immune activation markers during renal transplantation, and postulate that this method could be an accurate and rapid method of diagnosis of rejection.
37. Baggiolini M, Moser B. Blocking chemokine receptors. J Exp Med 1997; 186:1189-1191. The authors provide a short commentary on the idea that inflammation can be influenced by chemokine receptor antagonists.
38. Gong J-H, Ratkay LG, Waterfeild D, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997; 186:131-137.
39. Schols D, Struyf S, Van Damme J, Este JA, Henson G, De Clercq E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997; 186:1383-1388.
40. Murakami T, Nakajima T, Koyanagi Y, Tachibana K, Fujii N, Tamamura H, et al. A small molecule CXCR4 inhibitor that blocks T cell-line tropic HIV-1 infection. J Exp Wed 1997; 186:1389-1393.
41. Doranz BJ, Grovit-Ferbasi K, Sharron MP, Mao SH, Goetz MB, Daar ES, et al. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 1997; 186:1395-1400.